Bioventix (BVXP) Share Price, News & Analysis

Company Overview

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

Key Stats

• Today's Range: 3,110 to 3,300
• 50-Day Range: 3,101 to 3,975
• 52-Week Range: 2,977 to 5,100
• Volume: 4,279 shs
• Average Volume: 3,694 shs
• Market Capitalization: £164.68 million
• P/E Ratio: 1,935.41
• Dividend Yield: 5.01%
• Price Target: N/A
• Consensus Rating: N/A

BVXP Stock Analysis - Frequently Asked Questions

How have BVXP shares performed this year?

Bioventix's stock was trading at GBX 3,240 at the beginning of 2025. Since then, BVXP stock has decreased by 2.6% and is now trading at GBX 3,154.73.
View the best growth stocks for 2025 here.

How were Bioventix's earnings last quarter?

Bioventix PLC (LON:BVXP) issued its earnings results on Monday, March, 30th. The biotechnology company reported $69.28 earnings per share (EPS) for the quarter. Bioventix had a trailing twelve-month return on equity of 79.14% and a net margin of 63.73%.

How do I buy shares of Bioventix?

Shares of BVXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Bioventix own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Bioventix investors own include Lancashire (LRE), Avast (AVST), Victrex (VCT), boohoo group (BOO), Tullow Oil (TLW), Airbnb (ABNB) and Avon Protection (AVON).

Company Calendar

• Last Earnings: 3/30/2020
• Ex-Dividend for 11/21 Dividend: 11/07/2024
• Dividend Payable: 11/21/2024
• Today: 1/17/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Cannabis
• Current Symbol: LON:BVXP
• CUSIP: N/A
• CIK: N/A
• Web: www.bioventix.com
• Phone: +44-1252-728001
• Fax: N/A
• Employees: 12
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX 1.63
• Trailing P/E Ratio: 1,935.41
• Forward P/E Ratio: 18.97
• P/E Growth: N/A
• Net Income: £8.67 million
• Net Margins: 63.73%
• Pretax Margin: N/A
• Return on Equity: 79.14%
• Return on Assets: 54.07%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 7.04
• Quick Ratio: 5.50

Sales & Book Value

• Annual Sales: £13.60 million
• Price / Sales: 12.11
• Cash Flow: GBX 102.13 per share
• Price / Cash Flow: 30.89
• Book Value: GBX 219 per share
• Price / Book: 14.41

Miscellaneous

• Outstanding Shares: 5,220,000
• Free Float: N/A
• Market Cap: £164.68 million
• Optionable: Not Optionable
• Beta: 0.35